High-throughput measurement of human platelet aggregation under flow: application in hemostasis and beyond

References

• Baumgartner HR, Muggli R, Tschopp TB, Turitto VT. Platelet adhesion, release and aggregation in flowing blood: effects of surface properties and platelet function. Thromb Haemost. 1976; 35: 124–138.
   PubMed Web of Science ®Google Scholar
• Bolhuis PA, Sakariassen KS, Sixma JJ. Adhesion of blood platelets to human arterial subendothelium: role of factor VIII-Von Willebrand factor. Haemostasis. 1979; 8: 312–323.
   PubMedGoogle Scholar
• Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V. Influence of arterial damage and wall shear rate on platelet deposition. Ex Vivo Study in a Swine Model. Arteriosclerosis. 1986; 6: 312–320.
   PubMedGoogle Scholar
• Orvim U, Roald HE, Stephens RW, Roos N, Sakariassen KS. Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions. Arterioscler Thromb. 1994; 14: 1976–1983. doi:10.1161/01.ATV.14.12.1976.
   PubMedGoogle Scholar
• Sakariassen KS, Joss R, Muggli R, Kuhn H, Tschopp TB, Sage H, Baumgartner HR. Collagen type III induced ex vivo thrombogenesis in humans. Role of Platelets and Leukocytes in Deposition of Fibrin. Arteriosclerosis. 1990; 10: 276–284.
   PubMedGoogle Scholar
• De Groot PG, Sixma JJ. Perfusion chambers. In: Michelson AD. ed. Platelets. New York: Acad. Press; 2002. Chapter 24: p. 347–350.
   Google Scholar
• Hanson SR, Reidy MA, Hattori A, Harker LA. Pharmacologic modification of acute vascular graft thrombosis. Scan Electron Microsc. 1982; 2: 773–779.
   Google Scholar
• Weiss HJ, Turitto VT, Baumgartner HR. Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies Utilizing Patients with Quantitative and Qualitative Platelet Defects. J Clin Invest. 1986; 78: 1072–1082.
   PubMed Web of Science ®Google Scholar
• Sakariassen KS, Aarts PA, de Groot PG, Houdijk WP, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med. 1983; 102: 522–535.
   PubMed Web of Science ®Google Scholar
• Hubbell JA, McIntire LV. Technique for visualization and analysis of mural thrombogenesis. Rev Sci Instrum. 1986; 57: 892–897. doi:10.1063/1.1138830.
   Web of Science ®Google Scholar
• Heemskerk JW, Sakariassen KS, Zwaginga JJ, Brass LF, Jackson SP, Farndale RW. Collagen surfaces to measure thrombus formation under flow: possibilities for standardization. J Thromb Haemost. 2011; 9: 856–858. doi:10.1111/j.1538-7836.2011.04230.x.
   PubMed Web of Science ®Google Scholar
• Roest M, Reininger A, Jj Z, Mr K, Jw H. Flow chamber-based assays to measure thrombus formation in vitro: requirements for standardization. J Thromb Haemost. 2011; 9: 2322–2324. doi:10.1111/j.1538-7836.2011.04492.x.
   PubMed Web of Science ®Google Scholar
• Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998; 94: 657–666. doi:10.1016/S0092-8674(00)81607-4.
   PubMed Web of Science ®Google Scholar
• Siljander PR, Munnix IC, Smethurst PA, Deckmyn H, Lindhout T, Ouwehand WH, Farndale RW, Heemskerk JW. Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood. 2004; 103: 1333–1341. doi:10.1182/blood-2003-03-0889.
   PubMed Web of Science ®Google Scholar
• De Witt SM, Swieringa F, Cavill R, Lamers MM, van Kruchten R, Mastenbroek T, Baaten C, Coort S, Pugh N, Schulz A and others. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun. 2014; 5: 4257. doi:10.1038/ncomms5257.
   PubMed Web of Science ®Google Scholar
• Konopatskaya O, Matthews SA, Harper MT, Gilio K, Cosemans JM, Williams CM, Navarro MN, Carter DA, Heemskerk JW, Leitges M and others. Protein kinase C mediates platelet secretion and thrombus formation through protein kinase D2. Blood. 2011; 118: 416–424. doi:10.1182/blood-2010-10-312199.
   PubMed Web of Science ®Google Scholar
• Stegner D, Nieswandt B. Platelet receptor signaling in thrombus formation. J Mol Med (Berlin). 2011; 89: 109–121. doi:10.1007/s00109-010-0691-5.
   PubMed Web of Science ®Google Scholar
• Kuijpers MJ, Gilio K, Reitsma S, Nergiz-Unal R, Prinzen L, Heeneman S, Lutgens E, van Zandvoort MA, Nieswandt B, Egbrink MG and others. Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital model. J Thromb Haemost. 2009; 7: 152–161. doi:10.1111/j.1538-7836.2008.03186.x.
   PubMed Web of Science ®Google Scholar
• Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I, Rother E, Goetz C, Engelmann B, Smethurst PA and others. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. Faseb J. 2005; 19: 898–909. doi:10.1096/fj.04-2748com.
   PubMed Web of Science ®Google Scholar
• Cosemans JM, Kuijpers MJ, Lecut C, Loubele ST, Heeneman S, Jandrot-Perrus M, Heemskerk JW. Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis. 2005; 181: 19–27. doi:10.1016/j.atherosclerosis.2004.12.037.
   PubMed Web of Science ®Google Scholar
• Reininger AJ, Bernlochner I, Penz SM, Ravanat C, Smethurst P, Farndale RW, Gachet C, Brandl R, Siess W. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. J Am Coll Cardiol. 2010; 55: 1147–1158. doi:10.1016/j.jacc.2009.11.051.
   PubMed Web of Science ®Google Scholar
• Penz SM, Reininger AJ, Toth O, Deckmyn H, Brandl R, Siess W. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Thromb Haemost. 2007; 97: 435–443.
   PubMed Web of Science ®Google Scholar
• Nergiz-Unal R, Cosemans JM, Feijge MA, van der Meijden PE, Storey RF, van Giezen JJ, Oude Egbrink MG, Heemskerk JW, Kuijpers MJ. Stabilizing role of platelet P2Y12 receptors in shear-dependent thrombus formation on ruptured plaques. PLoS One. 2010; 5: e10130. doi:10.1371/journal.pone.0010130.
   PubMed Web of Science ®Google Scholar
• Van der Meijden PE, Munnix IC, Auger JM, Govers-Riemslag JW, Cosemans JM, Kuijpers MJ, Spronk HM, Watson SP, Renne T, Heemskerk JW. Dual role of collagen in factor XII-dependent thrombus formation. Blood. 2009; 114: 881–890. doi:10.1182/blood-2008-07-171066.
   PubMed Web of Science ®Google Scholar
• Colace TV, Muthard RW, Diamond SL. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin. Arterioscler Thromb Vasc Biol. 2012; 32: 1466–1476. doi:10.1161/ATVBAHA.112.249789.
   PubMed Web of Science ®Google Scholar
• Colace TV, Tormoen GW, McCarty OJ, Diamond SL. Microfluidics and coagulation biology. Annu Rev Biomed Eng. 2013; 15: 283–303. doi:10.1146/annurev-bioeng-071812-152406.
   PubMed Web of Science ®Google Scholar
• Van Kruchten R, Cosemans JM, Heemskerk JW. Measurement of whole blood thrombus formation using parallel-plate flow chambers - a practical guide. Platelets. 2012; 23: 229–242. doi:10.3109/09537104.2011.630848.
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002; 8: 1227–1234. doi:10.1038/nm1102-1227.
   PubMed Web of Science ®Google Scholar
• Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. 2013; 93: 327–358. doi:10.1152/physrev.00016.2011.
   PubMed Web of Science ®Google Scholar
• Nagy M, Mastenbroek TG, Mattheij NJA, de Witt S, Clemetson KJ, Kirschner J, Schulz AS, Vraetz T, Speckmann C, Braun A. et.al. Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies. Haematologica. 2018; 103: 540–549.
   PubMed Web of Science ®Google Scholar
• Stalker TJ, Traxler EA, Wu J, Wannemacher KM, Cermignano SL, Voronov R, Diamond SL, Brass LF. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood. 2013; 121: 1875–1885. doi:10.1182/blood-2012-09-457739.
   PubMed Web of Science ®Google Scholar
• Heemskerk JW, Mattheij NJ, Cosemans JM. Platelet-based coagulation: different populations, different functions. J Thromb Haemost. 2013; 11: 2–16. doi:10.1111/jth.12045.
   PubMed Web of Science ®Google Scholar
• Van Geffen JP, Swieringa F, Heemskerk JW. Platelets and coagulation in thrombus formation: aberrations in the Scott syndrome. Thromb Res. 2016; 141: S12–6. doi:10.1016/S0049-3848(16)30355-3.
   PubMed Web of Science ®Google Scholar
• Kuijpers MJ, Munnix IC, Cosemans JM, Vlijmen BV, Reutelingsperger CP, Egbrink MO, Heemskerk JW. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition. Microcirculation. 2008; 15: 269–282. doi:10.1080/10739680701653517.
   PubMed Web of Science ®Google Scholar
• Satta N, Toti F, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome: an inherited defect of the procoagulant activity of platelets. Platelets. 1997; 8: 117–124. doi:10.1080/09537109709169326.
   PubMed Web of Science ®Google Scholar
• Nurden AT, Nurden P. Inherited disorders of platelet function: selected updates. J Thromb Haemost. 2015; 13(Suppl 1): S2–9. doi:10.1111/jth.12898.
   PubMed Web of Science ®Google Scholar
• Mattheij NJ, Braun A, van Kruchten R, Castoldi E, Pircher J, Baaten CC, Wulling M, Kuijpers MJ, Kohler R, Poole AW and others. Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage. Faseb J. 2016; 30: 727–737. doi:10.1096/fj.15-280446.
   PubMed Web of Science ®Google Scholar
• Nagata S, Suzuki J, Segawa K, Fujii T. Exposure of phosphatidylserine on the cell surface. Cell Death Differ. 2016; 23: 952–961. doi:10.1038/cdd.2016.7.
   PubMed Web of Science ®Google Scholar
• Solari FA, Mattheij NJ, Burkhart JM, Swieringa F, Collins PW, Cosemans JM, Sickmann A, Heemskerk JW, Zahedi RP. Combined quantification of the global proteome, phosphoproteome, and proteolytic cleavage to characterize altered platelet functions in the human scott syndrome. Mol Cell Proteomics. 2016; 15: 3154–3169. doi:10.1074/mcp.M116.060368.
   PubMed Web of Science ®Google Scholar
• Nurden P, Nurden AT. Congenital disorders associated with platelet dysfunctions. Thromb Haemost. 2008; 99: 253–263.
   PubMed Web of Science ®Google Scholar
• Minami H, Nogami K, Ogiwara K, Furukawa S, Hosokawa K, Shima M. Use of a microchip flow-chamber system as a screening test for platelet storage pool disease. Int J Hematol. 2015; 102: 157–162. doi:10.1007/s12185-015-1819-8.
   PubMed Web of Science ®Google Scholar
• Tsuji S, Sugimoto M, Miyata S, Kuwahara M, Kinoshita S, Yoshioka A. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood. 1999; 94: 968–975.
   PubMed Web of Science ®Google Scholar
• Moroi M, Jung SM, Shinmyozu K, Tomiyama Y, Ordinas A, Diaz-Ricart M. Analysis of platelet adhesion to a collagen-coated surface under flow conditions: the involvement of glycoprotein VI in the platelet adhesion. Blood. 1996; 88: 2081–2092.
   PubMed Web of Science ®Google Scholar
• Kojima H, Moroi M, Jung SM, Goto S, Tamura N, Kozuma Y, Suzukawa K, Nagasawa T. Characterization of a patient with glycoprotein (GP) VI deficiency possessing neither anti-GPVI autoantibody nor genetic aberration. J Thromb Haemost. 2006; 4: 2433–2442. doi:10.1111/j.1538-7836.2006.02173.x.
   PubMed Web of Science ®Google Scholar
• Dumont B, Lasne D, Rothschild C, Bouabdelli M, Ollivier V, Oudin C, Ajzenberg N, Grandchamp B, Jandrot-Perrus M. Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood. 2009; 114: 1900–1903. doi:10.1182/blood-2009-03-213504.
   PubMed Web of Science ®Google Scholar
• Hermans C, Wittevrongel C, Thys C, Smethurst PA, Van Geet C, Freson K. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. J Thromb Haemost. 2009; 7: 1356–1363. doi:10.1111/j.1538-7836.2009.03520.x.
   PubMed Web of Science ®Google Scholar
• Petersen R, Lambourne JJ, Javierre BM, Grassi L, Kreuzhuber R, Ruklisa D, Rosa IM, Tome RA, Elding H, van Geffen JP and others. Platelet function is modified by common sequence variation in megakaryocyte super enhancer. Nat Commun. 2017; 8: 16058. doi:10.1038/ncomms16058.
   PubMed Web of Science ®Google Scholar
• Fressinaud E, Sakariassen KS, Rothschild C, Baumgartner HR, Meyer D. Shear rate-dependent impairment of thrombus growth on collagen in nonanticoagulated blood from patients with von Willebrand disease and hemophilia A. Blood. 1992; 80: 988–994.
   PubMed Web of Science ®Google Scholar
• Matsui H, Sugimoto M, Mizuno T, Tsuji S, Miyata S, Matsuda M, Yoshioka A. Distinct and concerted functions of von Willebrand factor and fibrinogen in mural thrombus growth under high shear flow. Blood. 2002; 100: 3604–3610. doi:10.1182/blood-2002-02-0508.
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Matsui H, Mizuno T, Tsuji S, Miyata S, Matsumoto M, Matsuda M, Fujimura Y, Yoshioka A. Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions. Blood. 2003; 101: 915–920. doi:10.1182/blood-2002-03-0944.
   PubMed Web of Science ®Google Scholar
• Hansen RR, Tipnis AA, White-Adams TC, Di Paola JA, Neeves KB. Characterization of collagen thin films for von Willebrand factor binding and platelet adhesion. Langmuir. 2011; 27: 13648–13658. doi:10.1021/la2023727.
   PubMed Web of Science ®Google Scholar
• Grabowski EF, Curran MA, Van Cott EM. Assessment of a cohort of primarily pediatric patients with a presumptive diagnosis of type 1 von Willebrand disease with a novel high shear rate, non-citrated blood flow device. Thromb Res. 2012; 129: e18–24. doi:10.1016/j.thromres.2011.12.016.
   PubMed Web of Science ®Google Scholar
• Onasoga-Jarvis AA, Leiderman K, Fogelson AL, Wang M, Manco-Johnson MJ, Di Paola JA, Neeves KB. The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models. PLoS One. 2013; 8: e78732. doi:10.1371/journal.pone.0078732.
   PubMed Web of Science ®Google Scholar
• Colace TV, Fogarty PF, Panckeri KA, Li R, Diamond SL. Microfluidic assay of hemophilic blood clotting: distinct deficits in platelet and fibrin deposition at low factor levels. J Thromb Haemost. 2014; 12: 147–158. doi:10.1111/jth.12457.
   PubMed Web of Science ®Google Scholar
• Mizuno T, Sugimoto M, Matsui H, Hamada M, Shida Y, Yoshioka A. Visual evaluation of blood coagulation during mural thrombogenesis under high shear blood flow. Thromb Res. 2008; 121: 855–864. doi:10.1016/j.thromres.2007.07.019.
   PubMed Web of Science ®Google Scholar
• Swieringa F, Kuijpers MJ, Lamers MM, van der Meijden PE, Heemskerk JW. Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow. Haematologica. 2015; 100: 748–756. doi:10.3324/haematol.2014.116863.
   PubMed Web of Science ®Google Scholar
• Swieringa F, Baaten CC, Verdoold R, Mastenbroek TG, Rijnveld N, van der Laan KO, Breel EJ, Collins PW, Lance MD, Henskens YM and others. Platelet control of fibrin distribution and microelasticity in thrombus formation under flow. Arterioscler Thromb Vasc Biol. 2016; 36: 692–699. doi:10.1161/ATVBAHA.115.306537.
   PubMed Web of Science ®Google Scholar
• Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, Mackway-Jones K, Parr MJ, Rizoli SB. Yukioka T and others. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008; 65: 748–754. doi:10.1097/TA.0b013e3181877a9c.
   PubMed Web of Science ®Google Scholar
• Van GJP, Kleinegris MC, Verdoold R, Baaten CC, Cosemans JM, Clemetson KJ, Ten Cate H, Roest M, de Laat B, Heemskerk JW. Normal platelet activation profile in patients with peripheral arterial disease on aspirin. Thromb Res. 2015; 135: 513–520. doi:10.1016/j.thromres.2014.12.029.
   PubMed Web of Science ®Google Scholar
• Cadroy Y, Bossavy JP, Thalamas C, Sagnard L, Sakariassen K, Boneu B. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation. 2000; 101: 2823–2828. doi:10.1161/01.CIR.101.24.2823.
   PubMed Web of Science ®Google Scholar
• Hernandez MR, Tonda R, Pedreno J, Salas E, Arderiu G, Pino M, Serradell M, Escolar G. Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity. J Cardiovasc Med. 2006; 7: 859–865. doi:10.2459/01.JCM.0000253829.17700.4f.
   Google Scholar
• Mendolicchio GL, Zavalloni D, Bacci M, Corrada E, Marconi M, Lodigiani C, Presbitero P, Rota L, Ruggeri ZM. Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood. J Thromb Haemost. 2011; 9: 373–382. doi:10.1111/j.1538-7836.2010.04144.x.
   PubMed Web of Science ®Google Scholar
• Lucitt MB, O’Brien S, Cowman J, Meade G, Basabe-Desmonts L, Somers M, Kent N, Ricco AJ, Kenny D. Assaying the efficacy of dual-antiplatelet therapy: use of a controlled-shear-rate microfluidic device with a well-defined collagen surface to track dynamic platelet adhesion. Anal Bioanal Chem. 2013; 405: 4823–4834. doi:10.1007/s00216-013-6897-y.
   PubMed Web of Science ®Google Scholar
• Bossavy JP, Thalamas C, Sagnard L, Barret A, Sakariassen K, Boneu B, Cadroy Y. A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans. Blood. 1998; 92: 1518–1525.
   PubMed Web of Science ®Google Scholar
• Florian P, Wonerow P, Harder S, Kuczka K, Dubar M, Graff J. Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber. Eur J Clin Pharmacol. 2017; 73: 949–956. doi:10.1007/s00228-017-2264-9.
   PubMed Web of Science ®Google Scholar
• Li R, Diamond SL. Detection of platelet sensitivity to inhibitors of COX1, P2Y1, and P2Y12 using a whole blood microfluidic flow assay. Thromb Res. 2014; 133: 203–210. doi:10.1016/j.thromres.2013.10.043.
   PubMed Web of Science ®Google Scholar
• Jahn K, Suchodolski K, Schafer A, Sahlmann B, Kuster U, Echtermeyer F, Calmer S, Theilmeier G, Johanning K. Effect of clopidogrel on thrombus tormation in an ex vivo parallel plate flow chamber model cannot be reversed by addition of platelet concentrates or vWF concentrate. Anesth Analg. 2017; 124: 1091–1098. doi:10.1213/ANE.0000000000001903.
   PubMed Web of Science ®Google Scholar
• Baaten CC, Veenstra LF, Wetzels R, van Geffen JP, Swieringa F, de Witt SM, Henskens YM, Crijns H, Nylander S, van Giezen JJ and others. Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication. Haematologica. 2015; 100: 1131–1138. doi:10.3324/haematol.2014.122457.
   PubMed Web of Science ®Google Scholar
• Maloney SF, Brass LF, Diamond SL. P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions. Integr Biol (Camb). 2010; 2: 183–192. doi:10.1039/b919728a.
   PubMed Web of Science ®Google Scholar
• Hosokawa K, Ohnishi T, Sameshima H, Miura N, Koide T, Maruyama I, Tanaka KA. Comparative evaluation of direct thrombin and factor Xa inhibitors with antiplatelet agents under flow and static conditions: an in vitro flow chamber model. PLoS One. 2014; 9: e86491. doi:10.1371/journal.pone.0086491.
   PubMed Web of Science ®Google Scholar
• Sugihara H, Idemoto Y, Kuwano T, Nagata Y, Morii J, Sugihara M, Ogawa M, Miura SI, Saku K. Evaluation of the antithrombotic effects of rivaroxaban and apixaban using the total thrombus-formation analysis system: in vitro and ex vivo studies. J Clin Med Res. 2016; 8: 899–907. doi:10.14740/jocmr2773w.
   PubMedGoogle Scholar
• Petzold T, Thienel M, Konrad I, Schubert I, Regenauer R, Hoppe B, Lorenz M, Eckart A, Chandraratne S, Lennerz C, Kolb C, Braun D, Jamasbi J, Brandl R, Braun S, Siess W, Schulz C, Massberg S. et.al. Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis. Sci Transl Med. 2016; 8: 367ra168. doi:10.1126/scitranslmed.aad6712.
   PubMed Web of Science ®Google Scholar
• Nagy M, Heemskerk JWM, Swieringa F. Use of microfluidics to assess the platelet-based control of coagulation. Platelets. 2017; 28: 441–448. doi:10.1080/09537104.2017.1293809.
   PubMed Web of Science ®Google Scholar
• De Witt S, Swieringa F, Cosemans JM, Heemskerk JW. Multi-parameter assessment of thrombus formation on microspotted arrays of thrombogenic surfaces. Nat Protocol Exchange. 2014; protocol number: 3382 doi:10.1038/protex.2014.026.
   Google Scholar
• Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez J-Y, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A, Schmid B and others. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012; 9: 676–682. doi:10.1038/nmeth.2019.
   PubMed Web of Science ®Google Scholar
• Li R, Fries S, Li X, Grosser T, Diamond SL. Microfluidic assay of platelet deposition on collagen by perfusion of whole blood from healthy individuals taking aspirin. Clin Chem. 2013; 59: 1195–1204. doi:10.1373/clinchem.2012.198101.
   PubMed Web of Science ®Google Scholar